ONC Q4 2023 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$634M+66.9% YoY

Gross Profit

$529M83.3% margin

Operating Income

-$384M-60.5% margin

Net Income

-$368M-57.9% margin

EPS (Diluted)

$-25.48

QoQ Revenue Growth

-18.8%

Cash Flow

Operating Cash Flow

-$222M

Free Cash Flow

-$389M

Stock-Based Comp.

$93M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$2.3B

Stockholders' Equity

$3.5B

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$634M	$380M	+66.9%
Gross Profit	$529M	$307M	+72.4%
Operating Income	-$384M	-$469M	+18.1%
Net Income	-$368M	-$445M	+17.5%